Overcoming venetoclax resistance in AML with MCL1 inhibition
Venetoclax monotherapy has yielded disappointing results in acute myeloid leukemia (AML) because resistance develops along with the propagation of MCL1-expressing clones. Here, Marina Konopleva, MD, P...
Author: VJHemOnc
Added: 09/21/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts